data_1mqx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mqx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 109.031 -0.729 . . . . 2.2400000000000002 109.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -97.03 -155.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.914 2.409 . . . . 1.23 112.509 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.55 91.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.808 -0.71 . . . . 2.3900000000000001 111.999 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.12 -97.55 0.11 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.804 -0.713 . . . . 2.1899999999999999 112.24 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.26 -37.25 1.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.57 -0.824 . . . . 2.23 112.87 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.24 166.47 14.17 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.814 -0.708 . . . . 1.3400000000000001 112.185 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.3 159.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.925 -0.398 . . . . 1.25 109.925 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.324 -0.538 0 C-N-CA 124.033 0.933 . . . . 0.33000000000000002 111.458 -178.414 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 CA--C 1.523 -0.06 0 N-CA-C 109.484 -0.561 . . . . 2.4399999999999999 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -105.01 -90.52 0.4 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.45 -0.796 . . . . 0.35999999999999999 110.044 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.9 mt . . . . . 0 N--CA 1.448 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.8999999999999999 111.279 -176.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.366 -0.605 . . . . 2.2400000000000002 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.654 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 95.1 Cg_endo -87.74 159.82 7.67 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.818 2.345 . . . . 1.23 113.22 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.47 -25.69 5.13 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.772 -0.649 . . . . 2.3900000000000001 111.665 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.87 164.46 31.22 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.971 -0.633 . . . . 2.1899999999999999 112.138 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.11 54.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.068 -0.587 . . . . 2.23 112.92 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.83 152.65 9.25 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.634 -0.793 . . . . 1.3400000000000001 111.912 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.654 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 19.8 t -120.54 159.65 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.982 -0.377 . . . . 1.25 109.982 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 34.6 t . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 124.258 1.023 . . . . 0.33000000000000002 111.299 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.231 0.113 0 N-CA-C 109.501 -0.555 . . . . 2.4399999999999999 109.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 m -87.9 -88.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.529 -0.76 . . . . 0.35999999999999999 109.541 173.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 20.6 mm . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.777 -0.647 . . . . 1.8999999999999999 110.187 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.186 -0.672 . . . . 2.2400000000000002 109.186 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.537 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.2 Cg_exo -71.33 -80.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.019 2.479 . . . . 1.23 112.826 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.46 5.84 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.83 -0.7 . . . . 2.3900000000000001 111.938 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.17 155.72 19.79 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.542 -0.837 . . . . 2.1899999999999999 112.743 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.0 29.74 68.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.023 -0.608 . . . . 2.23 112.713 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 140.45 5.9 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.037 -0.602 . . . . 1.3400000000000001 111.926 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.8 t -114.81 168.35 6.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.892 0.377 . . . . 1.25 110.278 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 4.3 t . . . . . 0 N--CA 1.441 -0.901 0 C-N-CA 123.163 0.585 . . . . 0.33000000000000002 110.324 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.318 0.58 . . . . 2.4399999999999999 109.695 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.8 m -89.19 -83.45 0.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.311 -0.859 . . . . 0.35999999999999999 109.279 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 57.7 mt . . . . . 0 N--CA 1.445 -0.704 0 CA-C-N 115.33 -0.85 . . . . 1.8999999999999999 111.029 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.135 -0.691 . . . . 2.2400000000000002 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 17.3 Cg_exo -69.37 -84.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.819 2.346 . . . . 1.23 112.444 -175.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 6' ' ' PRO . . . 97.87 45.32 2.47 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.396 -0.907 . . . . 2.3900000000000001 111.732 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.64 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.823 -0.703 . . . . 2.1899999999999999 112.779 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.2 89.48 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.508 -0.853 . . . . 2.23 112.887 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.67 158.25 23.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.692 -0.766 . . . . 1.3400000000000001 112.244 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.62 161.38 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.679 -0.489 . . . . 1.25 109.679 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 15.8 t . . . . . 0 C--N 1.323 -0.586 0 C-N-CA 123.655 0.782 . . . . 0.33000000000000002 111.097 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 121.343 0.592 . . . . 2.4399999999999999 109.404 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.4 m -104.86 -83.23 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.809 -1.087 . . . . 0.35999999999999999 108.65 170.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.418 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.2 mt . . . . . 0 N--CA 1.444 -0.76 0 CA-C-N 115.496 -0.775 . . . . 1.8999999999999999 110.905 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.6 pt? . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.098 0.475 . . . . 2.2400000000000002 110.361 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.622 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 43.1 Cg_endo -101.38 -165.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.246 2.63 . . . . 1.23 112.968 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.97 -30.36 1.24 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.091 -0.576 . . . . 2.3900000000000001 112.046 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.6 31.35 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.066 -0.587 . . . . 2.1899999999999999 111.818 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 39.27 23.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 2.23 112.39 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.43 134.69 6.53 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.869 -0.682 . . . . 1.3400000000000001 111.686 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.622 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 8.7 t -122.08 156.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.81 0.338 . . . . 1.25 110.462 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 124.178 0.991 . . . . 0.33000000000000002 110.852 178.473 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 109.373 -0.602 . . . . 2.4399999999999999 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.8 m -92.48 -95.83 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 0.35999999999999999 110.278 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-N 116.152 -0.476 . . . . 1.8999999999999999 111.269 -176.435 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 109.862 -0.421 . . . . 2.2400000000000002 109.862 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.53 -80.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.922 2.415 . . . . 1.23 112.139 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.81 2.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.462 -0.875 . . . . 2.3900000000000001 112.77 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.84 146.39 10.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.702 -0.761 . . . . 2.1899999999999999 112.147 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.01 -95.25 1.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.724 -0.551 . . . . 2.23 111.724 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.91 156.92 15.35 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.976 -0.849 . . . . 1.3400000000000001 110.976 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 157.83 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 1.25 110.494 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.33000000000000002 111.177 -179.731 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.458 -0.06 0 N-CA-C 109.514 -0.55 . . . . 2.4399999999999999 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -98.33 -98.44 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.35999999999999999 109.707 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.448 -0.528 0 CA-C-N 116.261 -0.427 . . . . 1.8999999999999999 110.828 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.164 -0.68 . . . . 2.2400000000000002 109.164 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -99.65 163.4 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.344 2.696 . . . . 1.23 112.943 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.28 31.18 6.34 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.632 . . . . 2.3900000000000001 111.74 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.85 159.59 21.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.1 -0.572 . . . . 2.1899999999999999 112.079 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.4 -103.4 2.62 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.182 -0.532 . . . . 2.23 112.803 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.84 -161.39 10.09 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.465 -0.654 . . . . 1.3400000000000001 111.465 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.39 161.37 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.244 0.545 . . . . 1.25 110.935 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.656 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 5.0 t . . . . . 0 N--CA 1.444 -0.751 0 CA-C-N 115.101 -0.954 . . . . 0.33000000000000002 110.37 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.309 0.576 . . . . 2.4399999999999999 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB2' ' H ' ' A' ' 19' ' ' ILE . 27.9 m -101.97 -85.12 0.44 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.35999999999999999 109.324 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.656 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 38.2 mm . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 115.568 -0.742 . . . . 1.8999999999999999 110.917 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.018 -0.734 . . . . 2.2400000000000002 109.018 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 83.3 Cg_endo -103.73 -155.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.144 2.563 . . . . 1.23 113.208 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 6' ' ' PRO . . . -172.13 89.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.859 -0.61 . . . . 2.3900000000000001 111.623 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.03 -155.21 12.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.992 -0.623 . . . . 2.1899999999999999 112.212 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.1 -31.47 74.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.158 -0.544 . . . . 2.23 112.682 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 151.09 18.4 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.64 -0.791 . . . . 1.3400000000000001 111.822 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 12' ' ' CYS . 4.8 t -120.7 160.0 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.06 -0.348 . . . . 1.25 110.06 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' N ' HG13 ' A' ' 11' ' ' VAL . 48.5 t . . . . . 0 C--N 1.324 -0.502 0 C-N-CA 123.647 0.779 . . . . 0.33000000000000002 111.021 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.161 -0.681 . . . . 2.4399999999999999 109.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -117.64 -83.27 0.64 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.469 -0.787 . . . . 0.35999999999999999 109.676 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 19' ' ' ILE . 41.1 mm . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.551 . . . . 1.8999999999999999 111.621 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.41 -0.589 . . . . 2.2400000000000002 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -97.68 -158.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.006 2.471 . . . . 1.23 112.404 -175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.18 42.06 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.353 -0.699 . . . . 2.3900000000000001 111.353 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -106.44 1.62 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.791 -0.718 . . . . 2.1899999999999999 112.255 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.86 -31.53 1.44 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.791 -0.718 . . . . 2.23 112.193 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 152.87 17.19 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.068 -0.587 . . . . 1.3400000000000001 111.636 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.53 166.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.848 0.356 . . . . 1.25 110.155 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 19.5 t . . . . . 0 N--CA 1.447 -0.599 0 C-N-CA 123.803 0.841 . . . . 0.33000000000000002 110.85 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.823 -0.806 . . . . 2.4399999999999999 108.823 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -88.97 -99.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 0.35999999999999999 109.764 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.487 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.5 mp . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 1.8999999999999999 110.293 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.441 -0.577 . . . . 2.2400000000000002 109.441 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.9 -81.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.267 2.645 . . . . 1.23 112.19 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.79 0.94 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.774 -0.727 . . . . 2.3900000000000001 112.297 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.99 -162.85 9.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.656 -0.783 . . . . 2.1899999999999999 112.236 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.28 90.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.186 -0.531 . . . . 2.23 112.138 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.81 107.26 1.58 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.193 -0.763 . . . . 1.3400000000000001 111.193 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.72 162.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.045 0.45 . . . . 1.25 110.879 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 42.4 t . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 114.977 -1.01 . . . . 0.33000000000000002 110.88 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.227 -0.114 0 N-CA-C 109.48 -0.563 . . . . 2.4399999999999999 109.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB2' ' H ' ' A' ' 19' ' ' ILE . 34.8 m -89.55 -84.18 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.35999999999999999 109.54 171.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 41.3 mt . . . . . 0 N--CA 1.446 -0.667 0 CA-C-N 115.292 -0.867 . . . . 1.8999999999999999 111.135 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.941 -0.392 . . . . 2.2400000000000002 109.941 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.734 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.5 Cg_exo -70.79 -73.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.064 2.51 . . . . 1.23 112.195 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.39 -24.25 8.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.835 -0.698 . . . . 2.3900000000000001 111.474 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.73 153.49 19.96 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.135 -0.786 . . . . 2.1899999999999999 111.135 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.71 -144.55 25.4 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.609 -0.805 . . . . 2.23 111.445 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.4 146.23 50.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.812 -0.709 . . . . 1.3400000000000001 111.813 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.734 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.6 t -114.62 166.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.026 0.413 . . . . 1.25 110.653 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 11.3 t . . . . . 0 N--CA 1.446 -0.634 0 C-N-CA 123.523 0.729 . . . . 0.33000000000000002 110.504 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.752 -0.462 . . . . 2.4399999999999999 109.752 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.617 ' HB3' HD11 ' A' ' 19' ' ' ILE . 60.0 m -88.78 -91.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.883 -0.599 . . . . 0.35999999999999999 109.808 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 18' ' ' CYS . 4.4 mp . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 116.286 -0.415 . . . . 1.8999999999999999 110.47 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.797 -0.446 . . . . 2.2400000000000002 109.797 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 55.7 Cg_endo -105.43 -99.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.422 2.748 . . . . 1.23 112.813 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.85 -145.23 6.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.339 -0.704 . . . . 2.3900000000000001 111.339 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.05 160.17 53.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.173 -0.536 . . . . 2.1899999999999999 112.674 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.63 1.41 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.137 -0.554 . . . . 2.23 112.365 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.89 106.57 2.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.969 -0.634 . . . . 1.3400000000000001 111.928 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.1 t -119.8 161.71 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.228 0.537 . . . . 1.25 110.783 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 7.2 t . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 124.194 0.998 . . . . 0.33000000000000002 110.628 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 109.761 -0.459 . . . . 2.4399999999999999 109.761 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' HB2' ' H ' ' A' ' 19' ' ' ILE . 56.9 m -88.82 -82.81 0.24 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.041 -0.726 . . . . 0.35999999999999999 109.041 173.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.696 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.5 mm . . . . . 0 N--CA 1.445 -0.706 0 CA-C-N 115.466 -0.788 . . . . 1.8999999999999999 110.68 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.587 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.641 -0.503 . . . . 3.6299999999999999 109.641 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.587 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.484 ' H ' ' HB2' ' A' ' 2' ' ' DBB . 0.2 OUTLIER -82.58 -160.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.601 0.239 . . . . 0.97999999999999998 110.614 175.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.411 ' H ' ' HB2' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.25 85.31 19.02 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.031 -0.729 . . . . 2.2400000000000002 109.031 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -97.03 -155.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.914 2.409 . . . . 1.23 112.509 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.55 91.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.808 -0.71 . . . . 2.3900000000000001 111.999 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.12 -97.55 0.11 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.804 -0.713 . . . . 2.1899999999999999 112.24 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.26 -37.25 1.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.57 -0.824 . . . . 2.23 112.87 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.24 166.47 14.17 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.814 -0.708 . . . . 1.3400000000000001 112.185 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.3 159.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.925 -0.398 . . . . 1.25 109.925 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 42.2 t -63.85 79.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.033 0.933 . . . . 0.33000000000000002 111.458 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.485 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 39.2 tp -152.99 -19.35 0.15 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.957 -1.929 . . . . 2.02 108.661 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.43 -18.58 31.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.473 -0.785 . . . . 2.4399999999999999 109.484 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 69.6 m -105.01 -90.52 0.4 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.45 -0.796 . . . . 0.35999999999999999 110.044 173.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.9 mt -104.41 -44.78 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.8999999999999999 111.279 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.466 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.595 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 112.316 0.487 . . . . 3.6299999999999999 112.316 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.595 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -65.51 155.61 35.1 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.134 -0.484 . . . . 0.97999999999999998 111.559 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.415 ' H ' ' HB2' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.58 87.91 22.62 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.644 -0.707 . . . . 2.2400000000000002 109.366 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.654 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 95.1 Cg_endo -87.74 159.82 7.67 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.818 2.345 . . . . 1.23 113.22 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.47 -25.69 5.13 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.772 -0.649 . . . . 2.3900000000000001 111.665 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.87 164.46 31.22 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.971 -0.633 . . . . 2.1899999999999999 112.138 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.11 54.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.068 -0.587 . . . . 2.23 112.92 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.83 152.65 9.25 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.634 -0.793 . . . . 1.3400000000000001 111.912 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.654 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 19.8 t -120.54 159.65 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.982 -0.377 . . . . 1.25 109.982 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 4' ' ' DBB . 34.6 t -61.91 80.46 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.258 1.023 . . . . 0.33000000000000002 111.299 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.533 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.0 tp -154.05 -27.98 0.13 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.316 -2.22 . . . . 2.02 107.504 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -89.38 -28.89 19.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.501 -0.555 . . . . 2.4399999999999999 109.501 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 54.1 m -87.9 -88.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.529 -0.76 . . . . 0.35999999999999999 109.541 173.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 20.6 mm -101.14 -78.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.777 -0.647 . . . . 1.8999999999999999 110.187 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.653 ' H1 ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 112.109 0.411 . . . . 3.6299999999999999 112.109 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.653 ' HA ' ' H1 ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.499 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -71.23 -169.14 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.391 -0.822 . . . . 0.97999999999999998 111.975 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.569 ' C ' ' HD3' ' A' ' 6' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.49 72.6 39.74 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 2.2400000000000002 109.186 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' HD3' ' C ' ' A' ' 4' ' ' DBB . 15.2 Cg_exo -71.33 -80.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.019 2.479 . . . . 1.23 112.826 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.46 5.84 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.83 -0.7 . . . . 2.3900000000000001 111.938 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.17 155.72 19.79 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.542 -0.837 . . . . 2.1899999999999999 112.743 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.0 29.74 68.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.023 -0.608 . . . . 2.23 112.713 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 140.45 5.9 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.037 -0.602 . . . . 1.3400000000000001 111.926 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.8 t -114.81 168.35 6.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.892 0.377 . . . . 1.25 110.278 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 4.3 t -74.07 71.72 1.63 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.163 0.585 . . . . 0.33000000000000002 110.324 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.463 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.1 tp -153.01 -25.5 0.15 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.199 -1.819 . . . . 2.02 108.309 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . 0.55 ' N ' ' HB2' ' A' ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -86.69 -36.85 18.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.621 -0.718 . . . . 2.4399999999999999 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 33.8 m -89.19 -83.45 0.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.311 -0.859 . . . . 0.35999999999999999 109.279 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 57.7 mt -101.79 -82.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.33 -0.85 . . . . 1.8999999999999999 111.029 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.55 ' HB2' ' N ' ' A' ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.684 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 36.4 t . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 120.342 0.115 . . . . 3.6299999999999999 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.684 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.408 ' H ' ' HB2' ' A' ' 2' ' ' DBB . 4.1 p90 -79.98 -156.08 0.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 0.97999999999999998 111.315 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.408 ' H ' ' HB2' ' A' ' 3' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -124.98 81.5 62.48 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.387 -0.824 . . . . 2.2400000000000002 109.135 169.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 17.3 Cg_exo -69.37 -84.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.819 2.346 . . . . 1.23 112.444 -175.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 6' ' ' PRO . . . 97.87 45.32 2.47 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.396 -0.907 . . . . 2.3900000000000001 111.732 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.64 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.823 -0.703 . . . . 2.1899999999999999 112.779 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.2 89.48 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.508 -0.853 . . . . 2.23 112.887 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.67 158.25 23.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.692 -0.766 . . . . 1.3400000000000001 112.244 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.62 161.38 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.679 -0.489 . . . . 1.25 109.679 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 15.8 t -68.19 76.34 0.24 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.655 0.782 . . . . 0.33000000000000002 111.097 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.468 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.95 -14.25 0.19 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.332 -1.758 . . . . 2.02 109.254 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.01 -18.3 30.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.343 0.592 . . . . 2.4399999999999999 109.404 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 36.4 m -104.86 -83.23 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.809 -1.087 . . . . 0.35999999999999999 108.65 170.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.418 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.2 mt -107.63 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.496 -0.775 . . . . 1.8999999999999999 110.905 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.791 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 1.8 t . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.542 -0.54 . . . . 3.6299999999999999 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.52 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.69 167.04 11.83 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.079 -0.509 . . . . 0.97999999999999998 112.048 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.65 ' HG2' HG23 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.6 pt? -151.04 95.08 3.43 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 121.098 0.475 . . . . 2.2400000000000002 110.361 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.622 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 43.1 Cg_endo -101.38 -165.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.246 2.63 . . . . 1.23 112.968 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.97 -30.36 1.24 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.091 -0.576 . . . . 2.3900000000000001 112.046 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.6 31.35 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.066 -0.587 . . . . 2.1899999999999999 111.818 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 39.27 23.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 2.23 112.39 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.43 134.69 6.53 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.869 -0.682 . . . . 1.3400000000000001 111.686 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.622 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 8.7 t -122.08 156.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.81 0.338 . . . . 1.25 110.462 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 4' ' ' DBB . 33.0 t -65.51 74.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.178 0.991 . . . . 0.33000000000000002 110.852 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.428 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.0 tm? -153.45 -25.93 0.14 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.201 -1.818 . . . . 2.02 108.016 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . 0.537 ' C ' ' HB2' ' A' ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . 0.735 ' N ' ' HB2' ' A' ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.59 -31.49 21.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.515 -0.766 . . . . 2.4399999999999999 109.373 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 85.8 m -92.48 -95.83 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 0.35999999999999999 110.278 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.65 HG23 ' HG2' ' A' ' 4' ' ' DBB . 56.0 mt -96.7 -46.62 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.152 -0.476 . . . . 1.8999999999999999 111.269 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.735 ' HB2' ' N ' ' A' ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.3 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.976 -0.75 . . . . 3.6299999999999999 108.976 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.52 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -179.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.97999999999999998 111.305 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.534 ' HG3' HG23 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.24 80.6 64.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.887 -0.597 . . . . 2.2400000000000002 109.862 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.53 -80.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.922 2.415 . . . . 1.23 112.139 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.81 2.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.462 -0.875 . . . . 2.3900000000000001 112.77 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.84 146.39 10.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.702 -0.761 . . . . 2.1899999999999999 112.147 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.01 -95.25 1.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.724 -0.551 . . . . 2.23 111.724 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.91 156.92 15.35 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.976 -0.849 . . . . 1.3400000000000001 110.976 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 157.83 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 1.25 110.494 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.5 t -64.92 81.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.33000000000000002 111.177 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.432 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.76 -19.15 0.14 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 112.539 -2.119 . . . . 2.02 108.208 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . 0.454 ' N ' ' HB2' ' A' ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.22 -26.57 24.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.412 -0.813 . . . . 2.4399999999999999 109.514 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 92.7 m -98.33 -98.44 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.35999999999999999 109.707 172.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.534 HG23 ' HG3' ' A' ' 4' ' ' DBB . 49.0 mt -84.34 -75.2 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.261 -0.427 . . . . 1.8999999999999999 110.828 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.454 ' HB2' ' N ' ' A' ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.635 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 44.6 t . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.271 0.1 . . . . 3.6299999999999999 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.635 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -80.5 -168.5 1.74 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.97999999999999998 111.334 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.521 ' HG1' HG23 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.56 84.11 53.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.164 -0.68 . . . . 2.2400000000000002 109.164 167.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -99.65 163.4 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.344 2.696 . . . . 1.23 112.943 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.28 31.18 6.34 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.632 . . . . 2.3900000000000001 111.74 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.85 159.59 21.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.1 -0.572 . . . . 2.1899999999999999 112.079 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.4 -103.4 2.62 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.182 -0.532 . . . . 2.23 112.803 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.84 -161.39 10.09 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.465 -0.654 . . . . 1.3400000000000001 111.465 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.39 161.37 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.244 0.545 . . . . 1.25 110.935 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.675 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 5.0 t -76.85 61.06 1.85 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.101 -0.954 . . . . 0.33000000000000002 110.37 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.539 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -153.34 -34.83 0.11 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.599 -1.637 . . . . 2.02 107.895 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . 0.432 ' C ' ' HB2' ' A' ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . 0.565 ' N ' ' HB2' ' A' ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -87.05 -28.31 22.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.788 -0.642 . . . . 2.4399999999999999 109.49 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 27.9 m -101.97 -85.12 0.44 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.35999999999999999 109.324 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.656 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 38.2 mm -96.32 -81.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.568 -0.742 . . . . 1.8999999999999999 110.917 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.675 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.0 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.6299999999999999 109.207 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.445 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.13 164.85 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.224 0.535 . . . . 0.97999999999999998 111.467 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.493 ' HG1' ' CG2' ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -122.69 84.77 49.07 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 2.2400000000000002 109.018 168.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 83.3 Cg_endo -103.73 -155.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.144 2.563 . . . . 1.23 113.208 -172.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 6' ' ' PRO . . . -172.13 89.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.859 -0.61 . . . . 2.3900000000000001 111.623 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.03 -155.21 12.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.992 -0.623 . . . . 2.1899999999999999 112.212 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.1 -31.47 74.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.158 -0.544 . . . . 2.23 112.682 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 151.09 18.4 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.64 -0.791 . . . . 1.3400000000000001 111.822 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 12' ' ' CYS . 4.8 t -120.7 160.0 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.06 -0.348 . . . . 1.25 110.06 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' N ' HG13 ' A' ' 11' ' ' VAL . 48.5 t -65.8 79.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.647 0.779 . . . . 0.33000000000000002 111.021 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.521 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 tp -153.52 -27.73 0.14 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.18 -1.827 . . . . 2.02 107.907 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -111.37 -14.53 13.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.789 -1.096 . . . . 2.4399999999999999 109.161 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 52.9 m -117.64 -83.27 0.64 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.469 -0.787 . . . . 0.35999999999999999 109.676 176.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.493 ' CG2' ' HG1' ' A' ' 4' ' ' DBB . 41.1 mm -102.35 -51.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.551 . . . . 1.8999999999999999 111.621 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.1 t . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.998 -0.741 . . . . 3.6299999999999999 108.998 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.431 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -171.23 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.708 . . . . 0.97999999999999998 111.781 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.478 ' HG1' HG23 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.12 91.71 44.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.611 -0.722 . . . . 2.2400000000000002 109.41 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -97.68 -158.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.006 2.471 . . . . 1.23 112.404 -175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.18 42.06 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.353 -0.699 . . . . 2.3900000000000001 111.353 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -106.44 1.62 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.791 -0.718 . . . . 2.1899999999999999 112.255 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.86 -31.53 1.44 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.791 -0.718 . . . . 2.23 112.193 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 152.87 17.19 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.068 -0.587 . . . . 1.3400000000000001 111.636 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.53 166.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.848 0.356 . . . . 1.25 110.155 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.533 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 19.5 t -69.34 71.42 0.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.803 0.841 . . . . 0.33000000000000002 110.85 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.447 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.7 tp -152.26 -24.56 0.18 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.924 -1.944 . . . . 2.02 108.367 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -85.93 -38.38 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.823 -0.806 . . . . 2.4399999999999999 108.823 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 71.0 m -88.97 -99.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 0.35999999999999999 109.764 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.487 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.5 mp -80.82 -81.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 1.8999999999999999 110.293 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.533 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.634 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 38.7 t . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.268 0.08 . . . . 3.6299999999999999 111.19 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.634 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.467 ' H ' ' HB2' ' A' ' 2' ' ' DBB . 0.7 OUTLIER -80.42 -156.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.97999999999999998 110.83 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.563 ' HG1' HG23 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.62 80.87 47.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 2.2400000000000002 109.441 168.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 4' ' ' DBB . 3.0 Cg_exo -77.9 -81.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.267 2.645 . . . . 1.23 112.19 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.79 0.94 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.774 -0.727 . . . . 2.3900000000000001 112.297 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.99 -162.85 9.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.656 -0.783 . . . . 2.1899999999999999 112.236 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.28 90.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.186 -0.531 . . . . 2.23 112.138 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.81 107.26 1.58 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.193 -0.763 . . . . 1.3400000000000001 111.193 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.72 162.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.045 0.45 . . . . 1.25 110.879 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 42.4 t -67.82 74.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.977 -1.01 . . . . 0.33000000000000002 110.88 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.477 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' O ' HD11 ' A' ' 14' ' ' LEU . 1.4 tm? -153.24 -25.17 0.15 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.426 -1.715 . . . . 2.02 108.196 171.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -86.26 -33.23 20.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 2.4399999999999999 109.48 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 34.8 m -89.55 -84.18 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.35999999999999999 109.54 171.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.563 HG23 ' HG1' ' A' ' 4' ' ' DBB . 41.3 mt -103.27 -70.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.292 -0.867 . . . . 1.8999999999999999 111.135 -176.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.502 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.684 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 111.899 0.333 . . . . 3.6299999999999999 111.899 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.684 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.464 ' H ' ' HB2' ' A' ' 2' ' ' DBB . 7.8 p90 -81.08 169.38 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 0.97999999999999998 110.977 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.513 ' HG3' HG22 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -121.59 82.75 40.94 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.309 -0.405 . . . . 2.2400000000000002 109.941 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.734 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.5 Cg_exo -70.79 -73.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.064 2.51 . . . . 1.23 112.195 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.39 -24.25 8.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.835 -0.698 . . . . 2.3900000000000001 111.474 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.73 153.49 19.96 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.135 -0.786 . . . . 2.1899999999999999 111.135 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.71 -144.55 25.4 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.609 -0.805 . . . . 2.23 111.445 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.4 146.23 50.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.812 -0.709 . . . . 1.3400000000000001 111.813 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.734 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.6 t -114.62 166.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.026 0.413 . . . . 1.25 110.653 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 11.3 t -72.32 73.55 0.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.523 0.729 . . . . 0.33000000000000002 110.504 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.405 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.5 tp -153.24 -27.73 0.14 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.694 -2.048 . . . . 2.02 107.665 169.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -87.46 -27.25 22.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 2.4399999999999999 109.752 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.617 ' HB3' HD11 ' A' ' 19' ' ' ILE . 60.0 m -88.78 -91.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.883 -0.599 . . . . 0.35999999999999999 109.808 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 18' ' ' CYS . 4.4 mp -99.22 -68.14 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.286 -0.415 . . . . 1.8999999999999999 110.47 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.627 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 31.1 t . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 110.967 -0.012 . . . . 3.6299999999999999 110.967 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' DBB . . . . . 0.627 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.473 ' HD1' ' SG ' ' A' ' 12' ' ' CYS . 33.1 p90 -70.36 154.74 41.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.481 . . . . 0.97999999999999998 111.012 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' DBB . . . . . 0.744 ' HG2' HG23 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.64 79.67 39.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.879 -0.601 . . . . 2.2400000000000002 109.797 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 55.7 Cg_endo -105.43 -99.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.422 2.748 . . . . 1.23 112.813 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.85 -145.23 6.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.339 -0.704 . . . . 2.3900000000000001 111.339 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.05 160.17 53.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.173 -0.536 . . . . 2.1899999999999999 112.674 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.63 1.41 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.137 -0.554 . . . . 2.23 112.365 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.89 106.57 2.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.969 -0.634 . . . . 1.3400000000000001 111.928 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.1 t -119.8 161.71 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.228 0.537 . . . . 1.25 110.783 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 7.2 t -76.1 64.66 1.99 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.194 0.998 . . . . 0.33000000000000002 110.628 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' DBB . . . . . 0.456 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.4 tp -153.23 -34.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.57 -2.105 . . . . 2.02 108.251 169.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' DHA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -89.07 -30.89 18.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.761 -0.459 . . . . 2.4399999999999999 109.761 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 56.9 m -88.82 -82.81 0.24 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.041 -0.726 . . . . 0.35999999999999999 109.041 173.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.744 HG23 ' HG2' ' A' ' 4' ' ' DBB . 29.5 mm -105.93 -79.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.466 -0.788 . . . . 1.8999999999999999 110.68 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TEE . . . . . 0.62 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 109.031 -0.729 . . . . 1.6299999999999999 109.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -97.03 -155.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.914 2.409 . . . . 1.23 112.509 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.55 91.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.808 -0.71 . . . . 2.3900000000000001 111.999 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.12 -97.55 0.11 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.804 -0.713 . . . . 1.9299999999999999 112.24 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.26 -37.25 1.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.57 -0.824 . . . . 2.23 112.87 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.24 166.47 14.17 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.814 -0.708 . . . . 0.89000000000000001 112.185 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 12' ' ' CYS . 9.9 t -117.3 159.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.925 -0.398 . . . . 0.63 109.925 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.413 ' N ' HG12 ' A' ' 11' ' ' VAL . 42.2 t . . . . . 0 C--N 1.324 -0.538 0 C-N-CA 124.033 0.933 . . . . 0.26000000000000001 111.458 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 CA--C 1.523 -0.06 0 N-CA-C 109.484 -0.561 . . . . 2.4399999999999999 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -105.01 -90.52 0.4 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.45 -0.796 . . . . 0.23999999999999999 110.044 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.408 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 32.9 mt . . . . . 0 N--CA 1.448 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.1899999999999999 111.279 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.366 -0.605 . . . . 1.6299999999999999 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.679 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 95.1 Cg_endo -87.74 159.82 7.67 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.818 2.345 . . . . 1.23 113.22 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.47 -25.69 5.13 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.772 -0.649 . . . . 2.3900000000000001 111.665 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.87 164.46 31.22 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.971 -0.633 . . . . 1.9299999999999999 112.138 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.11 54.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.068 -0.587 . . . . 2.23 112.92 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.83 152.65 9.25 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.634 -0.793 . . . . 0.89000000000000001 111.912 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.679 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 19.8 t -120.54 159.65 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.982 -0.377 . . . . 0.63 109.982 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 11' ' ' VAL . 34.6 t . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 124.258 1.023 . . . . 0.26000000000000001 111.299 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.231 0.113 0 N-CA-C 109.501 -0.555 . . . . 2.4399999999999999 109.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 m -87.9 -88.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.529 -0.76 . . . . 0.23999999999999999 109.541 173.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 20.6 mm . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 110.187 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.186 -0.672 . . . . 1.6299999999999999 109.186 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.54 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.2 Cg_exo -71.33 -80.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.019 2.479 . . . . 1.23 112.826 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.46 5.84 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.83 -0.7 . . . . 2.3900000000000001 111.938 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.17 155.72 19.79 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.542 -0.837 . . . . 1.9299999999999999 112.743 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.0 29.74 68.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.023 -0.608 . . . . 2.23 112.713 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 140.45 5.9 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.037 -0.602 . . . . 0.89000000000000001 111.926 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.8 t -114.81 168.35 6.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.892 0.377 . . . . 0.63 110.278 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.531 ' H ' HG12 ' A' ' 11' ' ' VAL . 4.3 t . . . . . 0 N--CA 1.441 -0.901 0 C-N-CA 123.163 0.585 . . . . 0.26000000000000001 110.324 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.318 0.58 . . . . 2.4399999999999999 109.695 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 19' ' ' ILE . 33.8 m -89.19 -83.45 0.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.311 -0.859 . . . . 0.23999999999999999 109.279 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.483 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 57.7 mt . . . . . 0 N--CA 1.445 -0.704 0 CA-C-N 115.33 -0.85 . . . . 1.1899999999999999 111.029 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.135 -0.691 . . . . 1.6299999999999999 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.37 -84.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.819 2.346 . . . . 1.23 112.444 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.87 45.32 2.47 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.396 -0.907 . . . . 2.3900000000000001 111.732 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.64 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.823 -0.703 . . . . 1.9299999999999999 112.779 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.2 89.48 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.508 -0.853 . . . . 2.23 112.887 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.67 158.25 23.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.692 -0.766 . . . . 0.89000000000000001 112.244 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 12' ' ' CYS . 6.3 t -118.62 161.38 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.679 -0.489 . . . . 0.63 109.679 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 11' ' ' VAL . 15.8 t . . . . . 0 C--N 1.323 -0.586 0 C-N-CA 123.655 0.782 . . . . 0.26000000000000001 111.097 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 121.343 0.592 . . . . 2.4399999999999999 109.404 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 19' ' ' ILE . 36.4 m -104.86 -83.23 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.809 -1.087 . . . . 0.23999999999999999 108.65 170.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.2 mt . . . . . 0 N--CA 1.444 -0.76 0 CA-C-N 115.496 -0.775 . . . . 1.1899999999999999 110.905 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.6 pt? . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.098 0.475 . . . . 1.6299999999999999 110.361 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 43.1 Cg_endo -101.38 -165.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.246 2.63 . . . . 1.23 112.968 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.97 -30.36 1.24 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.091 -0.576 . . . . 2.3900000000000001 112.046 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.6 31.35 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.066 -0.587 . . . . 1.9299999999999999 111.818 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 39.27 23.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 2.23 112.39 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.43 134.69 6.53 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.869 -0.682 . . . . 0.89000000000000001 111.686 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.657 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 8.7 t -122.08 156.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.81 0.338 . . . . 0.63 110.462 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 124.178 0.991 . . . . 0.26000000000000001 110.852 178.473 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 109.373 -0.602 . . . . 2.4399999999999999 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.8 m -92.48 -95.83 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 0.23999999999999999 110.278 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-N 116.152 -0.476 . . . . 1.1899999999999999 111.269 -176.435 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 109.862 -0.421 . . . . 1.6299999999999999 109.862 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.53 -80.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.922 2.415 . . . . 1.23 112.139 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.81 2.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.462 -0.875 . . . . 2.3900000000000001 112.77 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.84 146.39 10.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.702 -0.761 . . . . 1.9299999999999999 112.147 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.01 -95.25 1.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.724 -0.551 . . . . 2.23 111.724 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.91 156.92 15.35 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.976 -0.849 . . . . 0.89000000000000001 110.976 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 157.83 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.63 110.494 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.26000000000000001 111.177 -179.731 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.458 -0.06 0 N-CA-C 109.514 -0.55 . . . . 2.4399999999999999 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -98.33 -98.44 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 109.707 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.448 -0.528 0 CA-C-N 116.261 -0.427 . . . . 1.1899999999999999 110.828 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.164 -0.68 . . . . 1.6299999999999999 109.164 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -99.65 163.4 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.344 2.696 . . . . 1.23 112.943 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.28 31.18 6.34 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.632 . . . . 2.3900000000000001 111.74 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.85 159.59 21.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.1 -0.572 . . . . 1.9299999999999999 112.079 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.4 -103.4 2.62 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.182 -0.532 . . . . 2.23 112.803 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.84 -161.39 10.09 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.465 -0.654 . . . . 0.89000000000000001 111.465 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 12' ' ' CYS . 1.7 t -118.39 161.37 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.244 0.545 . . . . 0.63 110.935 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.665 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 5.0 t . . . . . 0 N--CA 1.444 -0.751 0 CA-C-N 115.101 -0.954 . . . . 0.26000000000000001 110.37 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.309 0.576 . . . . 2.4399999999999999 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.9 m -101.97 -85.12 0.44 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.23999999999999999 109.324 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 38.2 mm . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 115.568 -0.742 . . . . 1.1899999999999999 110.917 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.018 -0.734 . . . . 1.6299999999999999 109.018 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -103.73 -155.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.144 2.563 . . . . 1.23 113.208 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.13 89.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.859 -0.61 . . . . 2.3900000000000001 111.623 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.03 -155.21 12.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.992 -0.623 . . . . 1.9299999999999999 112.212 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.1 -31.47 74.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.158 -0.544 . . . . 2.23 112.682 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 151.09 18.4 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.64 -0.791 . . . . 0.89000000000000001 111.822 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 12' ' ' CYS . 4.8 t -120.7 160.0 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.06 -0.348 . . . . 0.63 110.06 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' N ' HG12 ' A' ' 11' ' ' VAL . 48.5 t . . . . . 0 C--N 1.324 -0.502 0 C-N-CA 123.647 0.779 . . . . 0.26000000000000001 111.021 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.161 -0.681 . . . . 2.4399999999999999 109.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -117.64 -83.27 0.64 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.469 -0.787 . . . . 0.23999999999999999 109.676 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.1 mm . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.551 . . . . 1.1899999999999999 111.621 -179.171 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.41 -0.589 . . . . 1.6299999999999999 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -97.68 -158.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.006 2.471 . . . . 1.23 112.404 -175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.18 42.06 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.353 -0.699 . . . . 2.3900000000000001 111.353 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -106.44 1.62 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.791 -0.718 . . . . 1.9299999999999999 112.255 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.86 -31.53 1.44 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.791 -0.718 . . . . 2.23 112.193 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 152.87 17.19 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.068 -0.587 . . . . 0.89000000000000001 111.636 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 12' ' ' CYS . 3.1 t -115.53 166.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.848 0.356 . . . . 0.63 110.155 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 19.5 t . . . . . 0 N--CA 1.447 -0.599 0 C-N-CA 123.803 0.841 . . . . 0.26000000000000001 110.85 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.823 -0.806 . . . . 2.4399999999999999 108.823 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -88.97 -99.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 0.23999999999999999 109.764 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 19' ' ' ILE . 4.5 mp . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 1.1899999999999999 110.293 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.441 -0.577 . . . . 1.6299999999999999 109.441 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.9 -81.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.267 2.645 . . . . 1.23 112.19 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.79 0.94 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.774 -0.727 . . . . 2.3900000000000001 112.297 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.99 -162.85 9.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.656 -0.783 . . . . 1.9299999999999999 112.236 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.28 90.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.186 -0.531 . . . . 2.23 112.138 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.81 107.26 1.58 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.193 -0.763 . . . . 0.89000000000000001 111.193 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.72 162.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.045 0.45 . . . . 0.63 110.879 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 42.4 t . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 114.977 -1.01 . . . . 0.26000000000000001 110.88 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.227 -0.114 0 N-CA-C 109.48 -0.563 . . . . 2.4399999999999999 109.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.55 -84.18 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.23999999999999999 109.54 171.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 41.3 mt . . . . . 0 N--CA 1.446 -0.667 0 CA-C-N 115.292 -0.867 . . . . 1.1899999999999999 111.135 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.941 -0.392 . . . . 1.6299999999999999 109.941 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.753 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.5 Cg_exo -70.79 -73.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.064 2.51 . . . . 1.23 112.195 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.39 -24.25 8.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.835 -0.698 . . . . 2.3900000000000001 111.474 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.73 153.49 19.96 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.135 -0.786 . . . . 1.9299999999999999 111.135 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.71 -144.55 25.4 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.609 -0.805 . . . . 2.23 111.445 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.4 146.23 50.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.812 -0.709 . . . . 0.89000000000000001 111.813 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.753 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.6 t -114.62 166.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.026 0.413 . . . . 0.63 110.653 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' H ' HG12 ' A' ' 11' ' ' VAL . 11.3 t . . . . . 0 N--CA 1.446 -0.634 0 C-N-CA 123.523 0.729 . . . . 0.26000000000000001 110.504 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.752 -0.462 . . . . 2.4399999999999999 109.752 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.681 ' HB3' HD12 ' A' ' 19' ' ' ILE . 60.0 m -88.78 -91.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.883 -0.599 . . . . 0.23999999999999999 109.808 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.681 HD12 ' HB3' ' A' ' 18' ' ' CYS . 4.4 mp . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 116.286 -0.415 . . . . 1.1899999999999999 110.47 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.797 -0.446 . . . . 1.6299999999999999 109.797 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 55.7 Cg_endo -105.43 -99.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.422 2.748 . . . . 1.23 112.813 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.85 -145.23 6.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.339 -0.704 . . . . 2.3900000000000001 111.339 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.05 160.17 53.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.173 -0.536 . . . . 1.9299999999999999 112.674 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.63 1.41 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.137 -0.554 . . . . 2.23 112.365 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.89 106.57 2.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.969 -0.634 . . . . 0.89000000000000001 111.928 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.1 t -119.8 161.71 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.228 0.537 . . . . 0.63 110.783 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 7.2 t . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 124.194 0.998 . . . . 0.26000000000000001 110.628 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 109.761 -0.459 . . . . 2.4399999999999999 109.761 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.9 m -88.82 -82.81 0.24 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.041 -0.726 . . . . 0.23999999999999999 109.041 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.707 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.5 mm . . . . . 0 N--CA 1.445 -0.706 0 CA-C-N 115.466 -0.788 . . . . 1.1899999999999999 110.68 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.62 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.641 -0.503 . . . . 3.0099999999999998 109.641 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.62 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -160.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.601 0.239 . . . . 0.81999999999999995 110.614 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.403 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.25 85.31 19.02 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.031 -0.729 . . . . 1.6299999999999999 109.031 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 4' ' ' DBB . 85.0 Cg_endo -97.03 -155.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.914 2.409 . . . . 1.23 112.509 -174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.55 91.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.808 -0.71 . . . . 2.3900000000000001 111.999 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.12 -97.55 0.11 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.804 -0.713 . . . . 1.9299999999999999 112.24 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.26 -37.25 1.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.57 -0.824 . . . . 2.23 112.87 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.24 166.47 14.17 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.814 -0.708 . . . . 0.89000000000000001 112.185 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 12' ' ' CYS . 9.9 t -117.3 159.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.925 -0.398 . . . . 0.63 109.925 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 42.2 t -63.85 79.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.033 0.933 . . . . 0.26000000000000001 111.458 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.512 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 39.2 tp -152.99 -19.35 0.15 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.957 -1.929 . . . . 1.3999999999999999 108.661 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.43 -18.58 31.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.473 -0.785 . . . . 2.4399999999999999 109.484 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 69.6 m -105.01 -90.52 0.4 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.45 -0.796 . . . . 0.23999999999999999 110.044 173.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.408 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 32.9 mt -104.41 -44.78 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.1899999999999999 111.279 -176.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TEE . . . . . 0.475 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.626 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 112.316 0.487 . . . . 3.0099999999999998 112.316 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.626 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -65.51 155.61 35.1 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.134 -0.484 . . . . 0.81999999999999995 111.559 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.58 87.91 22.62 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.644 -0.707 . . . . 1.6299999999999999 109.366 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.679 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 95.1 Cg_endo -87.74 159.82 7.67 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.818 2.345 . . . . 1.23 113.22 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.47 -25.69 5.13 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.772 -0.649 . . . . 2.3900000000000001 111.665 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.87 164.46 31.22 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.971 -0.633 . . . . 1.9299999999999999 112.138 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.11 54.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.068 -0.587 . . . . 2.23 112.92 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.83 152.65 9.25 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.634 -0.793 . . . . 0.89000000000000001 111.912 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.679 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 19.8 t -120.54 159.65 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.982 -0.377 . . . . 0.63 109.982 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 11' ' ' VAL . 34.6 t -61.91 80.46 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.258 1.023 . . . . 0.26000000000000001 111.299 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.472 ' HG2' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.0 tp -154.05 -27.98 0.13 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.316 -2.22 . . . . 1.3999999999999999 107.504 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -89.38 -28.89 19.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.501 -0.555 . . . . 2.4399999999999999 109.501 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 13' ' ' DBB . 54.1 m -87.9 -88.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.529 -0.76 . . . . 0.23999999999999999 109.541 173.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 20.6 mm -101.14 -78.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 110.187 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.603 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 112.109 0.411 . . . . 3.0099999999999998 112.109 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.603 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -71.23 -169.14 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.391 -0.822 . . . . 0.81999999999999995 111.975 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.575 ' C ' ' HD3' ' A' ' 6' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.49 72.6 39.74 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 1.6299999999999999 109.186 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD3' ' C ' ' A' ' 4' ' ' DBB . 15.2 Cg_exo -71.33 -80.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.019 2.479 . . . . 1.23 112.826 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.46 5.84 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.83 -0.7 . . . . 2.3900000000000001 111.938 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.17 155.72 19.79 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.542 -0.837 . . . . 1.9299999999999999 112.743 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.0 29.74 68.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.023 -0.608 . . . . 2.23 112.713 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 140.45 5.9 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.037 -0.602 . . . . 0.89000000000000001 111.926 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.8 t -114.81 168.35 6.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.892 0.377 . . . . 0.63 110.278 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 4.3 t -74.07 71.72 1.63 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.163 0.585 . . . . 0.26000000000000001 110.324 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.463 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.1 tp -153.01 -25.5 0.15 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.199 -1.819 . . . . 1.3999999999999999 108.309 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -86.69 -36.85 18.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.621 -0.718 . . . . 2.4399999999999999 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 33.8 m -89.19 -83.45 0.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.311 -0.859 . . . . 0.23999999999999999 109.279 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.484 HG21 ' HG1' ' A' ' 4' ' ' DBB . 57.7 mt -101.79 -82.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.33 -0.85 . . . . 1.1899999999999999 111.029 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TEE . . . . . 0.545 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.698 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 36.4 t . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 120.342 0.115 . . . . 3.0099999999999998 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.698 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.405 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 4.1 p90 -79.98 -156.08 0.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 0.81999999999999995 111.315 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -124.98 81.5 62.48 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.387 -0.824 . . . . 1.6299999999999999 109.135 169.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HG3' ' HA ' ' A' ' 3' ' ' PHE . 17.3 Cg_exo -69.37 -84.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.819 2.346 . . . . 1.23 112.444 -175.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.87 45.32 2.47 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.396 -0.907 . . . . 2.3900000000000001 111.732 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.64 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.823 -0.703 . . . . 1.9299999999999999 112.779 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.2 89.48 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.508 -0.853 . . . . 2.23 112.887 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.67 158.25 23.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.692 -0.766 . . . . 0.89000000000000001 112.244 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 12' ' ' CYS . 6.3 t -118.62 161.38 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.679 -0.489 . . . . 0.63 109.679 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.815 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 15.8 t -68.19 76.34 0.24 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.655 0.782 . . . . 0.26000000000000001 111.097 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.485 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.95 -14.25 0.19 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.332 -1.758 . . . . 1.3999999999999999 109.254 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.01 -18.3 30.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.343 0.592 . . . . 2.4399999999999999 109.404 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 36.4 m -104.86 -83.23 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.809 -1.087 . . . . 0.23999999999999999 108.65 170.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.2 mt -107.63 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.496 -0.775 . . . . 1.1899999999999999 110.905 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TEE . . . . . 0.815 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 1.8 t . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.542 -0.54 . . . . 3.0099999999999998 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.512 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.69 167.04 11.83 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.079 -0.509 . . . . 0.81999999999999995 112.048 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.6 pt? -151.04 95.08 3.43 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 121.098 0.475 . . . . 1.6299999999999999 110.361 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 43.1 Cg_endo -101.38 -165.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.246 2.63 . . . . 1.23 112.968 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.97 -30.36 1.24 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.091 -0.576 . . . . 2.3900000000000001 112.046 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.6 31.35 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.066 -0.587 . . . . 1.9299999999999999 111.818 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 39.27 23.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 2.23 112.39 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.43 134.69 6.53 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.869 -0.682 . . . . 0.89000000000000001 111.686 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.657 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 8.7 t -122.08 156.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.81 0.338 . . . . 0.63 110.462 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -65.51 74.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.178 0.991 . . . . 0.26000000000000001 110.852 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.483 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 14' ' ' LEU . 2.0 tm? -153.45 -25.93 0.14 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.201 -1.818 . . . . 1.3999999999999999 108.016 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.59 -31.49 21.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.515 -0.766 . . . . 2.4399999999999999 109.373 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 85.8 m -92.48 -95.83 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 0.23999999999999999 110.278 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 56.0 mt -96.7 -46.62 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.152 -0.476 . . . . 1.1899999999999999 111.269 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.3 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.976 -0.75 . . . . 3.0099999999999998 108.976 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.507 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -179.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.81999999999999995 111.305 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.24 80.6 64.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.887 -0.597 . . . . 1.6299999999999999 109.862 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.53 -80.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.922 2.415 . . . . 1.23 112.139 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.81 2.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.462 -0.875 . . . . 2.3900000000000001 112.77 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.84 146.39 10.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.702 -0.761 . . . . 1.9299999999999999 112.147 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.01 -95.25 1.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.724 -0.551 . . . . 2.23 111.724 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.91 156.92 15.35 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.976 -0.849 . . . . 0.89000000000000001 110.976 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 157.83 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.63 110.494 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.5 t -64.92 81.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.26000000000000001 111.177 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.459 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.76 -19.15 0.14 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 112.539 -2.119 . . . . 1.3999999999999999 108.208 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.22 -26.57 24.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.412 -0.813 . . . . 2.4399999999999999 109.514 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 92.7 m -98.33 -98.44 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 109.707 172.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.0 mt -84.34 -75.2 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.261 -0.427 . . . . 1.1899999999999999 110.828 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.655 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 44.6 t . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.271 0.1 . . . . 3.0099999999999998 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.655 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -80.5 -168.5 1.74 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.81999999999999995 111.334 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.432 ' O ' ' HB2' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.56 84.11 53.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.164 -0.68 . . . . 1.6299999999999999 109.164 167.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -99.65 163.4 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.344 2.696 . . . . 1.23 112.943 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.28 31.18 6.34 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.632 . . . . 2.3900000000000001 111.74 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.85 159.59 21.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.1 -0.572 . . . . 1.9299999999999999 112.079 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.4 -103.4 2.62 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.182 -0.532 . . . . 2.23 112.803 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.84 -161.39 10.09 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.465 -0.654 . . . . 0.89000000000000001 111.465 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 12' ' ' CYS . 1.7 t -118.39 161.37 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.244 0.545 . . . . 0.63 110.935 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 5.0 t -76.85 61.06 1.85 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.101 -0.954 . . . . 0.26000000000000001 110.37 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -153.34 -34.83 0.11 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.599 -1.637 . . . . 1.3999999999999999 107.895 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -87.05 -28.31 22.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.788 -0.642 . . . . 2.4399999999999999 109.49 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.9 m -101.97 -85.12 0.44 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.23999999999999999 109.324 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 38.2 mm -96.32 -81.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.568 -0.742 . . . . 1.1899999999999999 110.917 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TEE . . . . . 0.7 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.0 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.0099999999999998 109.207 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.439 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.13 164.85 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.224 0.535 . . . . 0.81999999999999995 111.467 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.473 ' HG1' ' HB ' ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -122.69 84.77 49.07 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 1.6299999999999999 109.018 168.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -103.73 -155.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.144 2.563 . . . . 1.23 113.208 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.13 89.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.859 -0.61 . . . . 2.3900000000000001 111.623 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.03 -155.21 12.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.992 -0.623 . . . . 1.9299999999999999 112.212 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.1 -31.47 74.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.158 -0.544 . . . . 2.23 112.682 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 151.09 18.4 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.64 -0.791 . . . . 0.89000000000000001 111.822 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 12' ' ' CYS . 4.8 t -120.7 160.0 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.06 -0.348 . . . . 0.63 110.06 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' N ' HG12 ' A' ' 11' ' ' VAL . 48.5 t -65.8 79.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.647 0.779 . . . . 0.26000000000000001 111.021 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.435 ' HG2' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 tp -153.52 -27.73 0.14 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.18 -1.827 . . . . 1.3999999999999999 107.907 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -111.37 -14.53 13.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.789 -1.096 . . . . 2.4399999999999999 109.161 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HG2' ' A' ' 13' ' ' DBB . 52.9 m -117.64 -83.27 0.64 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.469 -0.787 . . . . 0.23999999999999999 109.676 176.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' HB ' ' HG1' ' A' ' 4' ' ' DBB . 41.1 mm -102.35 -51.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.551 . . . . 1.1899999999999999 111.621 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.1 t . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.998 -0.741 . . . . 3.0099999999999998 108.998 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.424 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -171.23 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.708 . . . . 0.81999999999999995 111.781 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.12 91.71 44.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.611 -0.722 . . . . 1.6299999999999999 109.41 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -97.68 -158.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.006 2.471 . . . . 1.23 112.404 -175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.18 42.06 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.353 -0.699 . . . . 2.3900000000000001 111.353 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -106.44 1.62 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.791 -0.718 . . . . 1.9299999999999999 112.255 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.86 -31.53 1.44 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.791 -0.718 . . . . 2.23 112.193 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 152.87 17.19 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.068 -0.587 . . . . 0.89000000000000001 111.636 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 12' ' ' CYS . 3.1 t -115.53 166.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.848 0.356 . . . . 0.63 110.155 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.556 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 19.5 t -69.34 71.42 0.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.803 0.841 . . . . 0.26000000000000001 110.85 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.497 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.7 tp -152.26 -24.56 0.18 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.924 -1.944 . . . . 1.3999999999999999 108.367 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -85.93 -38.38 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.823 -0.806 . . . . 2.4399999999999999 108.823 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 71.0 m -88.97 -99.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 0.23999999999999999 109.764 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 19' ' ' ILE . 4.5 mp -80.82 -81.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 1.1899999999999999 110.293 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TEE . . . . . 0.556 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.657 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 38.7 t . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.268 0.08 . . . . 3.0099999999999998 111.19 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.657 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.433 ' H ' ' HB3' ' A' ' 2' ' ' DBB . 0.7 OUTLIER -80.42 -156.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.81999999999999995 110.83 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.42 ' C ' ' HD3' ' A' ' 6' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.62 80.87 47.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 1.6299999999999999 109.441 168.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 4' ' ' DBB . 3.0 Cg_exo -77.9 -81.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.267 2.645 . . . . 1.23 112.19 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.79 0.94 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.774 -0.727 . . . . 2.3900000000000001 112.297 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.99 -162.85 9.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.656 -0.783 . . . . 1.9299999999999999 112.236 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.28 90.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.186 -0.531 . . . . 2.23 112.138 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.81 107.26 1.58 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.193 -0.763 . . . . 0.89000000000000001 111.193 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.72 162.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.045 0.45 . . . . 0.63 110.879 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 42.4 t -67.82 74.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.977 -1.01 . . . . 0.26000000000000001 110.88 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.492 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 14' ' ' LEU . 1.4 tm? -153.24 -25.17 0.15 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.426 -1.715 . . . . 1.3999999999999999 108.196 171.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -86.26 -33.23 20.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 2.4399999999999999 109.48 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 34.8 m -89.55 -84.18 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.23999999999999999 109.54 171.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 41.3 mt -103.27 -70.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.292 -0.867 . . . . 1.1899999999999999 111.135 -176.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TEE . . . . . 0.517 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 111.899 0.333 . . . . 3.0099999999999998 111.899 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.703 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -81.08 169.38 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 0.81999999999999995 110.977 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.715 ' HG1' HG21 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -121.59 82.75 40.94 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.309 -0.405 . . . . 1.6299999999999999 109.941 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.753 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.5 Cg_exo -70.79 -73.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.064 2.51 . . . . 1.23 112.195 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.39 -24.25 8.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.835 -0.698 . . . . 2.3900000000000001 111.474 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.73 153.49 19.96 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.135 -0.786 . . . . 1.9299999999999999 111.135 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.71 -144.55 25.4 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.609 -0.805 . . . . 2.23 111.445 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.4 146.23 50.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.812 -0.709 . . . . 0.89000000000000001 111.813 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.753 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.6 t -114.62 166.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.026 0.413 . . . . 0.63 110.653 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' H ' HG12 ' A' ' 11' ' ' VAL . 11.3 t -72.32 73.55 0.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.523 0.729 . . . . 0.26000000000000001 110.504 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.461 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.5 tp -153.24 -27.73 0.14 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.694 -2.048 . . . . 1.3999999999999999 107.665 169.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -87.46 -27.25 22.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 2.4399999999999999 109.752 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.681 ' HB3' HD12 ' A' ' 19' ' ' ILE . 60.0 m -88.78 -91.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.883 -0.599 . . . . 0.23999999999999999 109.808 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG21 ' HG1' ' A' ' 4' ' ' DBB . 4.4 mp -99.22 -68.14 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.286 -0.415 . . . . 1.1899999999999999 110.47 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.645 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 31.1 t . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 110.967 -0.012 . . . . 3.0099999999999998 110.967 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' DBB . . . . . 0.645 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.474 ' HD1' ' SG ' ' A' ' 12' ' ' CYS . 33.1 p90 -70.36 154.74 41.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.481 . . . . 0.81999999999999995 111.012 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' DBB . . . . . 0.483 ' N ' ' HB2' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.64 79.67 39.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.879 -0.601 . . . . 1.6299999999999999 109.797 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 55.7 Cg_endo -105.43 -99.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.422 2.748 . . . . 1.23 112.813 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.85 -145.23 6.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.339 -0.704 . . . . 2.3900000000000001 111.339 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.05 160.17 53.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.173 -0.536 . . . . 1.9299999999999999 112.674 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.63 1.41 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.137 -0.554 . . . . 2.23 112.365 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.89 106.57 2.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.969 -0.634 . . . . 0.89000000000000001 111.928 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.1 t -119.8 161.71 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.228 0.537 . . . . 0.63 110.783 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 7.2 t -76.1 64.66 1.99 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.194 0.998 . . . . 0.26000000000000001 110.628 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' DBB . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.4 tp -153.23 -34.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.57 -2.105 . . . . 1.3999999999999999 108.251 169.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -89.07 -30.89 18.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.761 -0.459 . . . . 2.4399999999999999 109.761 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.453 ' HB3' ' HG2' ' A' ' 13' ' ' DBB . 56.9 m -88.82 -82.81 0.24 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.041 -0.726 . . . . 0.23999999999999999 109.041 173.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.707 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.5 mm -105.93 -79.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.466 -0.788 . . . . 1.1899999999999999 110.68 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TEE . . . . . 0.643 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 109.031 -0.729 . . . . 1.63 109.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -97.03 -155.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.914 2.409 . . . . 1.23 112.509 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.55 91.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.808 -0.71 . . . . 2.39 111.999 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.12 -97.55 0.11 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.804 -0.713 . . . . 1.93 112.24 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.26 -37.25 1.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.57 -0.824 . . . . 2.23 112.87 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.24 166.47 14.17 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.814 -0.708 . . . . 0.89 112.185 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 12' ' ' CYS . 9.9 t -117.3 159.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.925 -0.398 . . . . 0.63 109.925 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.413 ' N ' HG12 ' A' ' 11' ' ' VAL . 42.2 t . . . . . 0 C--N 1.324 -0.538 0 C-N-CA 124.033 0.933 . . . . 0.26 111.458 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 CA--C 1.523 -0.06 0 N-CA-C 109.484 -0.561 . . . . 2.44 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -105.01 -90.52 0.4 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.45 -0.796 . . . . 0.24 110.044 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.408 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 32.9 mt . . . . . 0 N--CA 1.448 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.19 111.279 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.366 -0.605 . . . . 1.63 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.679 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 95.1 Cg_endo -87.74 159.82 7.67 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.818 2.345 . . . . 1.23 113.22 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.47 -25.69 5.13 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.772 -0.649 . . . . 2.39 111.665 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.87 164.46 31.22 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.971 -0.633 . . . . 1.93 112.138 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.11 54.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.068 -0.587 . . . . 2.23 112.92 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.83 152.65 9.25 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.634 -0.793 . . . . 0.89 111.912 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.679 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 19.8 t -120.54 159.65 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.982 -0.377 . . . . 0.63 109.982 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 11' ' ' VAL . 34.6 t . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 124.258 1.023 . . . . 0.26 111.299 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.231 0.113 0 N-CA-C 109.501 -0.555 . . . . 2.44 109.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 m -87.9 -88.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.529 -0.76 . . . . 0.24 109.541 173.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 20.6 mm . . . . . 0 N--CA 1.446 -0.644 0 CA-C-N 115.777 -0.647 . . . . 1.19 110.187 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.186 -0.672 . . . . 1.63 109.186 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.54 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.2 Cg_exo -71.33 -80.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.019 2.479 . . . . 1.23 112.826 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.46 5.84 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.83 -0.7 . . . . 2.39 111.938 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.17 155.72 19.79 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.542 -0.837 . . . . 1.93 112.743 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.0 29.74 68.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.023 -0.608 . . . . 2.23 112.713 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 140.45 5.9 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.037 -0.602 . . . . 0.89 111.926 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.8 t -114.81 168.35 6.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.892 0.377 . . . . 0.63 110.278 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.531 ' H ' HG12 ' A' ' 11' ' ' VAL . 4.3 t . . . . . 0 N--CA 1.441 -0.901 0 C-N-CA 123.163 0.585 . . . . 0.26 110.324 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.318 0.58 . . . . 2.44 109.695 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 19' ' ' ILE . 33.8 m -89.19 -83.45 0.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.311 -0.859 . . . . 0.24 109.279 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.483 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 57.7 mt . . . . . 0 N--CA 1.445 -0.704 0 CA-C-N 115.33 -0.85 . . . . 1.19 111.029 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.135 -0.691 . . . . 1.63 109.135 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.37 -84.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.819 2.346 . . . . 1.23 112.444 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.87 45.32 2.47 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.396 -0.907 . . . . 2.39 111.732 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.64 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.823 -0.703 . . . . 1.93 112.779 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.2 89.48 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.508 -0.853 . . . . 2.23 112.887 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.67 158.25 23.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.692 -0.766 . . . . 0.89 112.244 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 12' ' ' CYS . 6.3 t -118.62 161.38 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.679 -0.489 . . . . 0.63 109.679 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 11' ' ' VAL . 15.8 t . . . . . 0 C--N 1.323 -0.586 0 C-N-CA 123.655 0.782 . . . . 0.26 111.097 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.455 -0.225 0 CA-C-O 121.343 0.592 . . . . 2.44 109.404 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 19' ' ' ILE . 36.4 m -104.86 -83.23 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.809 -1.087 . . . . 0.24 108.65 170.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.2 mt . . . . . 0 N--CA 1.444 -0.76 0 CA-C-N 115.496 -0.775 . . . . 1.19 110.905 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 pt? . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.098 0.475 . . . . 1.63 110.361 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 43.1 Cg_endo -101.38 -165.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.246 2.63 . . . . 1.23 112.968 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.97 -30.36 1.24 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.091 -0.576 . . . . 2.39 112.046 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.6 31.35 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.066 -0.587 . . . . 1.93 111.818 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 39.27 23.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 2.23 112.39 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.43 134.69 6.53 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.869 -0.682 . . . . 0.89 111.686 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.657 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 8.7 t -122.08 156.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.81 0.338 . . . . 0.63 110.462 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 124.178 0.991 . . . . 0.26 110.852 178.473 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 109.373 -0.602 . . . . 2.44 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.8 m -92.48 -95.83 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 0.24 110.278 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-N 116.152 -0.476 . . . . 1.19 111.269 -176.435 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 109.862 -0.421 . . . . 1.63 109.862 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.53 -80.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.922 2.415 . . . . 1.23 112.139 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.81 2.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.462 -0.875 . . . . 2.39 112.77 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.84 146.39 10.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.702 -0.761 . . . . 1.93 112.147 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.01 -95.25 1.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.724 -0.551 . . . . 2.23 111.724 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.91 156.92 15.35 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.976 -0.849 . . . . 0.89 110.976 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 157.83 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.63 110.494 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.26 111.177 -179.731 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.458 -0.06 0 N-CA-C 109.514 -0.55 . . . . 2.44 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -98.33 -98.44 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.24 109.707 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.448 -0.528 0 CA-C-N 116.261 -0.427 . . . . 1.19 110.828 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.164 -0.68 . . . . 1.63 109.164 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -99.65 163.4 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.344 2.696 . . . . 1.23 112.943 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.28 31.18 6.34 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.632 . . . . 2.39 111.74 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.85 159.59 21.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.1 -0.572 . . . . 1.93 112.079 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.4 -103.4 2.62 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.182 -0.532 . . . . 2.23 112.803 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.84 -161.39 10.09 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.465 -0.654 . . . . 0.89 111.465 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 12' ' ' CYS . 1.7 t -118.39 161.37 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.244 0.545 . . . . 0.63 110.935 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.665 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 5.0 t . . . . . 0 N--CA 1.444 -0.751 0 CA-C-N 115.101 -0.954 . . . . 0.26 110.37 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.309 0.576 . . . . 2.44 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.9 m -101.97 -85.12 0.44 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.24 109.324 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 38.2 mm . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 115.568 -0.742 . . . . 1.19 110.917 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.018 -0.734 . . . . 1.63 109.018 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -103.73 -155.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.144 2.563 . . . . 1.23 113.208 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.13 89.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.859 -0.61 . . . . 2.39 111.623 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.03 -155.21 12.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.992 -0.623 . . . . 1.93 112.212 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.1 -31.47 74.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.158 -0.544 . . . . 2.23 112.682 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 151.09 18.4 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.64 -0.791 . . . . 0.89 111.822 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 12' ' ' CYS . 4.8 t -120.7 160.0 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.06 -0.348 . . . . 0.63 110.06 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' N ' HG12 ' A' ' 11' ' ' VAL . 48.5 t . . . . . 0 C--N 1.324 -0.502 0 C-N-CA 123.647 0.779 . . . . 0.26 111.021 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.161 -0.681 . . . . 2.44 109.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -117.64 -83.27 0.64 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.469 -0.787 . . . . 0.24 109.676 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.1 mm . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.551 . . . . 1.19 111.621 -179.171 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.41 -0.589 . . . . 1.63 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -97.68 -158.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.006 2.471 . . . . 1.23 112.404 -175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.18 42.06 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.353 -0.699 . . . . 2.39 111.353 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -106.44 1.62 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.791 -0.718 . . . . 1.93 112.255 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.86 -31.53 1.44 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.791 -0.718 . . . . 2.23 112.193 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 152.87 17.19 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.068 -0.587 . . . . 0.89 111.636 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 12' ' ' CYS . 3.1 t -115.53 166.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.848 0.356 . . . . 0.63 110.155 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 19.5 t . . . . . 0 N--CA 1.447 -0.599 0 C-N-CA 123.803 0.841 . . . . 0.26 110.85 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.823 -0.806 . . . . 2.44 108.823 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -88.97 -99.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 0.24 109.764 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 19' ' ' ILE . 4.5 mp . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 1.19 110.293 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.441 -0.577 . . . . 1.63 109.441 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.9 -81.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.267 2.645 . . . . 1.23 112.19 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.79 0.94 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.774 -0.727 . . . . 2.39 112.297 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.99 -162.85 9.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.656 -0.783 . . . . 1.93 112.236 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.28 90.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.186 -0.531 . . . . 2.23 112.138 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.81 107.26 1.58 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.193 -0.763 . . . . 0.89 111.193 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.72 162.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.045 0.45 . . . . 0.63 110.879 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 42.4 t . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 114.977 -1.01 . . . . 0.26 110.88 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--O 1.227 -0.114 0 N-CA-C 109.48 -0.563 . . . . 2.44 109.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.55 -84.18 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.24 109.54 171.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 41.3 mt . . . . . 0 N--CA 1.446 -0.667 0 CA-C-N 115.292 -0.867 . . . . 1.19 111.135 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.941 -0.392 . . . . 1.63 109.941 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.753 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.5 Cg_exo -70.79 -73.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.064 2.51 . . . . 1.23 112.195 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.39 -24.25 8.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.835 -0.698 . . . . 2.39 111.474 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.73 153.49 19.96 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.135 -0.786 . . . . 1.93 111.135 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.71 -144.55 25.4 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.609 -0.805 . . . . 2.23 111.445 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.4 146.23 50.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.812 -0.709 . . . . 0.89 111.813 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.753 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.6 t -114.62 166.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.026 0.413 . . . . 0.63 110.653 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' H ' HG12 ' A' ' 11' ' ' VAL . 11.3 t . . . . . 0 N--CA 1.446 -0.634 0 C-N-CA 123.523 0.729 . . . . 0.26 110.504 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.752 -0.462 . . . . 2.44 109.752 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.681 ' HB3' HD12 ' A' ' 19' ' ' ILE . 60.0 m -88.78 -91.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.883 -0.599 . . . . 0.24 109.808 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.681 HD12 ' HB3' ' A' ' 18' ' ' CYS . 4.4 mp . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 116.286 -0.415 . . . . 1.19 110.47 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.797 -0.446 . . . . 1.63 109.797 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 55.7 Cg_endo -105.43 -99.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.422 2.748 . . . . 1.23 112.813 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.85 -145.23 6.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.339 -0.704 . . . . 2.39 111.339 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.05 160.17 53.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.173 -0.536 . . . . 1.93 112.674 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.63 1.41 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.137 -0.554 . . . . 2.23 112.365 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.89 106.57 2.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.969 -0.634 . . . . 0.89 111.928 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.1 t -119.8 161.71 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.228 0.537 . . . . 0.63 110.783 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 7.2 t . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 124.194 0.998 . . . . 0.26 110.628 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 109.761 -0.459 . . . . 2.44 109.761 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.9 m -88.82 -82.81 0.24 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.041 -0.726 . . . . 0.24 109.041 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.707 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.5 mm . . . . . 0 N--CA 1.445 -0.706 0 CA-C-N 115.466 -0.788 . . . . 1.19 110.68 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.62 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.641 -0.503 . . . . 3.01 109.641 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.62 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -160.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.601 0.239 . . . . 0.82 110.614 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.403 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.25 85.31 19.02 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.031 -0.729 . . . . 1.63 109.031 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 4' ' ' DBB . 85.0 Cg_endo -97.03 -155.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.914 2.409 . . . . 1.23 112.509 -174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.55 91.23 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.808 -0.71 . . . . 2.39 111.999 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.12 -97.55 0.11 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.804 -0.713 . . . . 1.93 112.24 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.26 -37.25 1.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.57 -0.824 . . . . 2.23 112.87 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.24 166.47 14.17 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.814 -0.708 . . . . 0.89 112.185 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 12' ' ' CYS . 9.9 t -117.3 159.04 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.925 -0.398 . . . . 0.63 109.925 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 42.2 t -63.85 79.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.033 0.933 . . . . 0.26 111.458 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.512 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 39.2 tp -152.99 -19.35 0.15 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.957 -1.929 . . . . 1.4 108.661 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.43 -18.58 31.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.473 -0.785 . . . . 2.44 109.484 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 69.6 m -105.01 -90.52 0.4 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.45 -0.796 . . . . 0.24 110.044 173.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.408 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 32.9 mt -104.41 -44.78 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.19 111.279 -176.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . 0.475 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.626 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 112.316 0.487 . . . . 3.01 112.316 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.626 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -65.51 155.61 35.1 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.134 -0.484 . . . . 0.82 111.559 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.58 87.91 22.62 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.644 -0.707 . . . . 1.63 109.366 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.679 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 95.1 Cg_endo -87.74 159.82 7.67 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.818 2.345 . . . . 1.23 113.22 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.47 -25.69 5.13 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.772 -0.649 . . . . 2.39 111.665 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.87 164.46 31.22 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.971 -0.633 . . . . 1.93 112.138 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.11 54.16 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.068 -0.587 . . . . 2.23 112.92 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.83 152.65 9.25 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.634 -0.793 . . . . 0.89 111.912 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.679 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 19.8 t -120.54 159.65 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.982 -0.377 . . . . 0.63 109.982 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 11' ' ' VAL . 34.6 t -61.91 80.46 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.258 1.023 . . . . 0.26 111.299 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.472 ' HG2' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.0 tp -154.05 -27.98 0.13 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.316 -2.22 . . . . 1.4 107.504 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -89.38 -28.89 19.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.501 -0.555 . . . . 2.44 109.501 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 13' ' ' DBB . 54.1 m -87.9 -88.89 0.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.529 -0.76 . . . . 0.24 109.541 173.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 20.6 mm -101.14 -78.24 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.777 -0.647 . . . . 1.19 110.187 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.603 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 112.109 0.411 . . . . 3.01 112.109 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.603 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -71.23 -169.14 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.391 -0.822 . . . . 0.82 111.975 -176.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.575 ' C ' ' HD3' ' A' ' 6' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.49 72.6 39.74 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 1.63 109.186 168.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD3' ' C ' ' A' ' 4' ' ' DBB . 15.2 Cg_exo -71.33 -80.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.019 2.479 . . . . 1.23 112.826 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.46 5.84 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.83 -0.7 . . . . 2.39 111.938 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.17 155.72 19.79 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.542 -0.837 . . . . 1.93 112.743 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.0 29.74 68.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.023 -0.608 . . . . 2.23 112.713 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 140.45 5.9 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.037 -0.602 . . . . 0.89 111.926 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.8 t -114.81 168.35 6.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.892 0.377 . . . . 0.63 110.278 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 4.3 t -74.07 71.72 1.63 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.163 0.585 . . . . 0.26 110.324 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.463 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.1 tp -153.01 -25.5 0.15 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.199 -1.819 . . . . 1.4 108.309 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -86.69 -36.85 18.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.621 -0.718 . . . . 2.44 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 33.8 m -89.19 -83.45 0.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.311 -0.859 . . . . 0.24 109.279 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.484 HG21 ' HG1' ' A' ' 4' ' ' DBB . 57.7 mt -101.79 -82.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.33 -0.85 . . . . 1.19 111.029 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . 0.545 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.698 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 36.4 t . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 120.342 0.115 . . . . 3.01 111.234 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.698 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.405 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 4.1 p90 -79.98 -156.08 0.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 0.82 111.315 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -124.98 81.5 62.48 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.387 -0.824 . . . . 1.63 109.135 169.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HG3' ' HA ' ' A' ' 3' ' ' PHE . 17.3 Cg_exo -69.37 -84.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.819 2.346 . . . . 1.23 112.444 -175.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.87 45.32 2.47 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.396 -0.907 . . . . 2.39 111.732 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.64 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.823 -0.703 . . . . 1.93 112.779 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.2 89.48 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.508 -0.853 . . . . 2.23 112.887 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.67 158.25 23.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.692 -0.766 . . . . 0.89 112.244 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 12' ' ' CYS . 6.3 t -118.62 161.38 17.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.679 -0.489 . . . . 0.63 109.679 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.815 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 15.8 t -68.19 76.34 0.24 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 123.655 0.782 . . . . 0.26 111.097 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.485 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.95 -14.25 0.19 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.332 -1.758 . . . . 1.4 109.254 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -87.01 -18.3 30.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.343 0.592 . . . . 2.44 109.404 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 36.4 m -104.86 -83.23 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.809 -1.087 . . . . 0.24 108.65 170.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.2 mt -107.63 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.496 -0.775 . . . . 1.19 110.905 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . 0.815 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 1.8 t . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.542 -0.54 . . . . 3.01 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.512 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.69 167.04 11.83 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.079 -0.509 . . . . 0.82 112.048 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 pt? -151.04 95.08 3.43 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 121.098 0.475 . . . . 1.63 110.361 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' A' ' 11' ' ' VAL . 43.1 Cg_endo -101.38 -165.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.246 2.63 . . . . 1.23 112.968 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.97 -30.36 1.24 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.091 -0.576 . . . . 2.39 112.046 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.6 31.35 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.066 -0.587 . . . . 1.93 111.818 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 39.27 23.11 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 2.23 112.39 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.43 134.69 6.53 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.869 -0.682 . . . . 0.89 111.686 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.657 ' HA ' ' HG3' ' A' ' 6' ' ' PRO . 8.7 t -122.08 156.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.81 0.338 . . . . 0.63 110.462 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.0 t -65.51 74.22 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.178 0.991 . . . . 0.26 110.852 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.483 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 14' ' ' LEU . 2.0 tm? -153.45 -25.93 0.14 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.201 -1.818 . . . . 1.4 108.016 170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.59 -31.49 21.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.515 -0.766 . . . . 2.44 109.373 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 85.8 m -92.48 -95.83 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 0.24 110.278 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 56.0 mt -96.7 -46.62 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.152 -0.476 . . . . 1.19 111.269 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.3 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.976 -0.75 . . . . 3.01 108.976 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.507 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -179.43 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.281 0.562 . . . . 0.82 111.305 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.24 80.6 64.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.887 -0.597 . . . . 1.63 109.862 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.53 -80.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.922 2.415 . . . . 1.23 112.139 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.81 2.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.462 -0.875 . . . . 2.39 112.77 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.84 146.39 10.54 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.702 -0.761 . . . . 1.93 112.147 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.01 -95.25 1.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.724 -0.551 . . . . 2.23 111.724 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.91 156.92 15.35 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.976 -0.849 . . . . 0.89 110.976 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 157.83 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 117.254 0.527 . . . . 0.63 110.494 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.5 t -64.92 81.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.26 111.177 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.459 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.76 -19.15 0.14 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 112.539 -2.119 . . . . 1.4 108.208 169.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -86.22 -26.57 24.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.412 -0.813 . . . . 2.44 109.514 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 92.7 m -98.33 -98.44 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.482 -0.781 . . . . 0.24 109.707 172.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.0 mt -84.34 -75.2 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 116.261 -0.427 . . . . 1.19 110.828 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.655 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 44.6 t . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.271 0.1 . . . . 3.01 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.655 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -80.5 -168.5 1.74 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.82 111.334 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.432 ' O ' ' HB2' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.56 84.11 53.17 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.164 -0.68 . . . . 1.63 109.164 167.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -99.65 163.4 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.344 2.696 . . . . 1.23 112.943 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.28 31.18 6.34 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.632 . . . . 2.39 111.74 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.85 159.59 21.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.1 -0.572 . . . . 1.93 112.079 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.4 -103.4 2.62 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.182 -0.532 . . . . 2.23 112.803 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.84 -161.39 10.09 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.465 -0.654 . . . . 0.89 111.465 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 12' ' ' CYS . 1.7 t -118.39 161.37 17.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.244 0.545 . . . . 0.63 110.935 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 5.0 t -76.85 61.06 1.85 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.101 -0.954 . . . . 0.26 110.37 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -153.34 -34.83 0.11 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.599 -1.637 . . . . 1.4 107.895 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -87.05 -28.31 22.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.788 -0.642 . . . . 2.44 109.49 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 27.9 m -101.97 -85.12 0.44 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.24 109.324 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 38.2 mm -96.32 -81.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.568 -0.742 . . . . 1.19 110.917 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . 0.7 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.0 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.01 109.207 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.439 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.13 164.85 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.224 0.535 . . . . 0.82 111.467 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.473 ' HG1' ' HB ' ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -122.69 84.77 49.07 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.396 -0.82 . . . . 1.63 109.018 168.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -103.73 -155.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.144 2.563 . . . . 1.23 113.208 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.13 89.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.859 -0.61 . . . . 2.39 111.623 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.03 -155.21 12.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.992 -0.623 . . . . 1.93 112.212 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.1 -31.47 74.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.158 -0.544 . . . . 2.23 112.682 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.75 151.09 18.4 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.64 -0.791 . . . . 0.89 111.822 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 12' ' ' CYS . 4.8 t -120.7 160.0 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.06 -0.348 . . . . 0.63 110.06 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' N ' HG12 ' A' ' 11' ' ' VAL . 48.5 t -65.8 79.08 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.647 0.779 . . . . 0.26 111.021 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.435 ' HG2' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 tp -153.52 -27.73 0.14 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.18 -1.827 . . . . 1.4 107.907 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -111.37 -14.53 13.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.789 -1.096 . . . . 2.44 109.161 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HG2' ' A' ' 13' ' ' DBB . 52.9 m -117.64 -83.27 0.64 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.469 -0.787 . . . . 0.24 109.676 176.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' HB ' ' HG1' ' A' ' 4' ' ' DBB . 41.1 mm -102.35 -51.76 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.989 -0.551 . . . . 1.19 111.621 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 2' ' ' DBB . 2.1 t . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.998 -0.741 . . . . 3.01 108.998 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.424 ' HA ' ' HB3' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -171.23 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.708 . . . . 0.82 111.781 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.12 91.71 44.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.611 -0.722 . . . . 1.63 109.41 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -97.68 -158.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.006 2.471 . . . . 1.23 112.404 -175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.18 42.06 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.353 -0.699 . . . . 2.39 111.353 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -106.44 1.62 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.791 -0.718 . . . . 1.93 112.255 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.86 -31.53 1.44 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.791 -0.718 . . . . 2.23 112.193 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 152.87 17.19 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.068 -0.587 . . . . 0.89 111.636 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 12' ' ' CYS . 3.1 t -115.53 166.28 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.848 0.356 . . . . 0.63 110.155 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.556 ' HB3' ' SG ' ' A' ' 20' ' ' TEE . 19.5 t -69.34 71.42 0.28 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.803 0.841 . . . . 0.26 110.85 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.497 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.7 tp -152.26 -24.56 0.18 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 112.924 -1.944 . . . . 1.4 108.367 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -85.93 -38.38 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.823 -0.806 . . . . 2.44 108.823 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 71.0 m -88.97 -99.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.72 -0.673 . . . . 0.24 109.764 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 19' ' ' ILE . 4.5 mp -80.82 -81.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 1.19 110.293 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . 0.556 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.657 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 38.7 t . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.268 0.08 . . . . 3.01 111.19 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.657 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.433 ' H ' ' HB3' ' A' ' 2' ' ' DBB . 0.7 OUTLIER -80.42 -156.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.82 110.83 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.42 ' C ' ' HD3' ' A' ' 6' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.62 80.87 47.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.919 -0.582 . . . . 1.63 109.441 168.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 4' ' ' DBB . 3.0 Cg_exo -77.9 -81.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.267 2.645 . . . . 1.23 112.19 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.79 0.94 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.774 -0.727 . . . . 2.39 112.297 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.99 -162.85 9.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.656 -0.783 . . . . 1.93 112.236 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.28 90.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.186 -0.531 . . . . 2.23 112.138 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.81 107.26 1.58 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.193 -0.763 . . . . 0.89 111.193 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.72 162.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.045 0.45 . . . . 0.63 110.879 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.518 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 42.4 t -67.82 74.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.977 -1.01 . . . . 0.26 110.88 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.492 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 14' ' ' LEU . 1.4 tm? -153.24 -25.17 0.15 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.426 -1.715 . . . . 1.4 108.196 171.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -86.26 -33.23 20.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 2.44 109.48 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 13' ' ' DBB . 34.8 m -89.55 -84.18 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.24 109.54 171.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 41.3 mt -103.27 -70.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.292 -0.867 . . . . 1.19 111.135 -176.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . 0.517 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' N ' ' HA ' ' A' ' 2' ' ' DBB . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 111.899 0.333 . . . . 3.01 111.899 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.703 ' HA ' ' N ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -81.08 169.38 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 0.82 110.977 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.715 ' HG1' HG21 ' A' ' 19' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -121.59 82.75 40.94 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.309 -0.405 . . . . 1.63 109.941 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.753 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 15.5 Cg_exo -70.79 -73.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.064 2.51 . . . . 1.23 112.195 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.39 -24.25 8.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.835 -0.698 . . . . 2.39 111.474 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.73 153.49 19.96 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.135 -0.786 . . . . 1.93 111.135 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.71 -144.55 25.4 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.609 -0.805 . . . . 2.23 111.445 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.4 146.23 50.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.812 -0.709 . . . . 0.89 111.813 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.753 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.6 t -114.62 166.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.026 0.413 . . . . 0.63 110.653 -177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' H ' HG12 ' A' ' 11' ' ' VAL . 11.3 t -72.32 73.55 0.97 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.523 0.729 . . . . 0.26 110.504 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.461 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.5 tp -153.24 -27.73 0.14 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 112.694 -2.048 . . . . 1.4 107.665 169.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -87.46 -27.25 22.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 2.44 109.752 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.681 ' HB3' HD12 ' A' ' 19' ' ' ILE . 60.0 m -88.78 -91.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.883 -0.599 . . . . 0.24 109.808 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.715 HG21 ' HG1' ' A' ' 4' ' ' DBB . 4.4 mp -99.22 -68.14 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.286 -0.415 . . . . 1.19 110.47 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.645 ' HA ' ' C ' ' A' ' 2' ' ' DBB . 31.1 t . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 110.967 -0.012 . . . . 3.01 110.967 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' DBB . . . . . 0.645 ' C ' ' HA ' ' A' ' 1' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.474 ' HD1' ' SG ' ' A' ' 12' ' ' CYS . 33.1 p90 -70.36 154.74 41.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.109 0.481 . . . . 0.82 111.012 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' DBB . . . . . 0.483 ' N ' ' HB2' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.64 79.67 39.19 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.879 -0.601 . . . . 1.63 109.797 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HG2' ' HA ' ' A' ' 11' ' ' VAL . 55.7 Cg_endo -105.43 -99.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.422 2.748 . . . . 1.23 112.813 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.85 -145.23 6.3 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.339 -0.704 . . . . 2.39 111.339 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.05 160.17 53.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.173 -0.536 . . . . 1.93 112.674 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.25 -100.63 1.41 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.137 -0.554 . . . . 2.23 112.365 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.89 106.57 2.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.969 -0.634 . . . . 0.89 111.928 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 6' ' ' PRO . 2.1 t -119.8 161.71 18.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.228 0.537 . . . . 0.63 110.783 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 19' ' ' ILE . 7.2 t -76.1 64.66 1.99 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.194 0.998 . . . . 0.26 110.628 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' DBB . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.4 tp -153.23 -34.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.57 -2.105 . . . . 1.4 108.251 169.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' DHA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -89.07 -30.89 18.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.761 -0.459 . . . . 2.44 109.761 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.453 ' HB3' ' HG2' ' A' ' 13' ' ' DBB . 56.9 m -88.82 -82.81 0.24 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.041 -0.726 . . . . 0.24 109.041 173.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.707 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.5 mm -105.93 -79.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.466 -0.788 . . . . 1.19 110.68 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TEE . . . . . 0.643 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_